Position statement on radiopharmaceutical production for clinical trials

Position statement on radiopharmaceutical production for clinical trials

Abstract The EU regulation 536/2014 aims to facilitate the experimental use of diagnostic radiopharmaceuticals in particular for GMP requirements and needs to be applied in EU countries. As definitely clarified by this survey, the application is still far from being completed due to national restric...

Full description

Bibliographic Details
Main Authors: G. Bormans, A. Buck, A. Chiti, M. Cooper, J. Croasdale, M. Desruet, V. Kumar, Y. Liu, I. Penuelas, C. Rossetti, R. Schiavo, S. W. Schwarz, A. D. Windhorst
Format: Article
Language:English
Published: SpringerOpen 2017-09-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Radiopharmaceuticals
Regulatory
Clinical trials
Online Access:http://link.springer.com/article/10.1186/s41181-017-0031-y

Internet

http://link.springer.com/article/10.1186/s41181-017-0031-y

Similar Items